产品描述信息
NR-15645??Mycobacterium tuberculosis, CDC1551, Transposon Mutant 1511 (MT1059, Rv1030)(Mutant Bacteria)|Mycobacterium tuberculosis|CDC1551, Transposon Mutant 1511 (MT1059, Rv1030)||NIH - TB Vaccine Testing and Research Materials ContractAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Mycobacterium tuberculosis, Strain CDC1551, Transposon Mutant 1511 (MT1059, Rv1030), NR-15645."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.In 2002,
TARGET (Tuberculosis Animal Research and Gene Evaluation Taskforce) was formed to enable the modeling of human tuberculosis in multiple animal species using defined protocols and testing defined mutants of M. tuberculosis. In addition to animal modeling activities, a library of intragenic transposon mutants has been created and characterized. M. tuberculosis, transposon mutant 1511 was created by disruption of a probable potassium-transporting ATPase, B subunit, (MT1059, Rv1030), of the wild-type strain CDC1551.Each tube contains a Lowenstein-Jensen (LJ) agar slant that was inoculated with 0.1 mL of bacterial culture and incubated 2 to 4 weeks at 37°C.TARGET:
Rv1030MT Number (JCVI):
MT1059TubercuList:
Rv1030Orf Description: probable potassium-transporting ATPase, B subunitOrf Size: 2130POI: 2050Additional information is available at
Mycobacterium tuberculosis CDC1551 Transposon Mutant Library.This mutant was developed by Lamichhane, et al. at the Center for Tuberculosis Research, The Johns Hopkins University School of Medicine, PubMed:
12775759.